ScreenerHero

BIOVIC-BBiovica International AB (publ)

STO · SE · Healthcare · Biotechnology · biovica.com
0.4480SEK-4.68%Mkt Cap: 12.51M $P/E: —

Biovica International AB (publ), a biotech company, develops and commercializes blood-based biomarker assays for oncologists monitor cancer progression in the European Union, the United States, and Asia. The company enga…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap12.51M $
Enterprise Value6.80M $
Revenue (TTM)1.29M $
Gross Profit1.28M $
Net Income (TTM)-6.68M $
Revenue/Share0.0055 USD
Last Price0.4480 SEK
Fiscal Year EndApr 2026
MR QuarterApr 2026
Employees25
CountrySE
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.43
PEG—
EV/EBITDA-1.02
EV/Revenue5.27
P/S9.59
P/B1.50
EPS (TTM)-0.30
EPS (Forward)-1.04
52W Range
0.270043% of range0.6860
52W High0.6860 SEK
52W Low0.2700 SEK
Profitability
Gross Margin99.68%
Oper. Margin-368.80%
EBITDA Margin0.00%
Profit Margin-522.12%
ROE-80.92%
ROA-64.84%
Growth
Revenue Growth108.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.01M $
CapEx (TTM)45.34K $
FCF Margin-290.83%
FCF Yield-29.99%
Net Debt-6.32M $
Net Debt/EBITDA0.95
Balance Sheet
Debt/Equity0.05
Current Ratio4.30
Quick Ratio4.06
Book Value/Sh0.2960 SEK
Cash/Share0.2410 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)0.6000 SEK
Upside (mean)+33.9%
Target Range0.6000 SEK – 0.6000 SEK
# Analysts1
Ownership
Shares Out.277.49M
Float167.10M
Insiders0.00%
Institutions0.01%
Technical
SMA 500.4382 (+2.2%)
SMA 2000.4094 (+9.4%)
Beta1.16
S&P 52W Chg18.16%
Avg Vol (30d)621.24K
Avg Vol (10d)427.89K
Technical Indicators
RSI (14)42.7
MACD0.0135
MACD Signal0.0257
MACD Hist.-0.0123
BB Upper0.5582 SEK
BB Middle0.5064 SEK
BB Lower0.4547 SEK
BB Width20.44%
ATR (14)0.0462 SEK
Vol Ratio (20d)0.97x